BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11768328)

  • 1. The apicoplast as an antimalarial drug target.
    Ralph SA; D'Ombrain MC; McFadden GI
    Drug Resist Updat; 2001 Jun; 4(3):145-51. PubMed ID: 11768328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria, Plasmodium falciparum and its apicoplast.
    Kalanon M; McFadden GI
    Biochem Soc Trans; 2010 Jun; 38(3):775-82. PubMed ID: 20491664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
    Touze JE; Fourcade L; Pradines B; Hovette P; Paule P; Heno P
    Med Trop (Mars); 2002; 62(3):219-24. PubMed ID: 12244914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Golgi-independent transport from the early secretory pathway to the plastid in malaria parasites.
    Tonkin CJ; Struck NS; Mullin KA; Stimmler LM; McFadden GI
    Mol Microbiol; 2006 Aug; 61(3):614-30. PubMed ID: 16787449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein targeting to the malaria parasite plastid.
    Tonkin CJ; Kalanon M; McFadden GI
    Traffic; 2008 Feb; 9(2):166-75. PubMed ID: 17900270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current antimalarial drugs: resistance and new strategies].
    Ringwald P
    Bull Acad Natl Med; 2007 Oct; 191(7):1273-84; discussion 1284. PubMed ID: 18447049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to reverse drug resistance in malaria.
    Egan TJ; Kaschula CH
    Curr Opin Infect Dis; 2007 Dec; 20(6):598-604. PubMed ID: 17975410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets.
    Müller IB; Hyde JE; Wrenger C
    Trends Parasitol; 2010 Jan; 26(1):35-43. PubMed ID: 19939733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of anti-bacterials on the malaria parasite Plasmodium falciparum.
    Goodman CD; Su V; McFadden GI
    Mol Biochem Parasitol; 2007 Apr; 152(2):181-91. PubMed ID: 17289168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old and new targets for innovative antimalarial compounds: the different strategies of the Italian Malaria Network.
    Basilico N; Bosisio E; Buelli F; Campiani G; Casagrande M; Castelli F; Coghi P; Corbett Y; Cortelezzi L; D'Alessandro S; Dell'Agli M; Esposito F; Fattorusso C; Fattorusso E; Finaurini S; Galli GV; Gemma S; Habluetzel A; Lucantoni L; Melato S; Monti D; Olliaro P; Omodeo-Salè F; Parapini S; Persico M; Rizzi M; Romeo S; Rossi F; Rusconi C; Sparatore A; Scafati OT; van den Bogaart E; Taramelli D; Vaiana N; Yerbanga S
    Parassitologia; 2008 Jun; 50(1-2):133-6. PubMed ID: 18693579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum.
    Qidwai T; Priya A; Khan NA; Tripathi H; Khan F; Darokar MP; Pal A; Bawankule DU; Shukla RK; Bhakuni RS
    Curr Drug Targets; 2014 Apr; 15(4):374-409. PubMed ID: 23848395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development.
    Chakraborty A
    Life Sci; 2016 Aug; 158():104-10. PubMed ID: 27381078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics.
    Dahl EL; Rosenthal PJ
    Trends Parasitol; 2008 Jun; 24(6):279-84. PubMed ID: 18450512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial drug therapy: the role of parasite biology and drug resistance.
    Daily JP
    J Clin Pharmacol; 2006 Dec; 46(12):1487-97. PubMed ID: 17101748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.